1.
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
by Iribarren, Carlos, MD, MPH, PhD
Journal of allergy and clinical immunology, 2016, Vol.139 (5), p.1489-1495.e5
2.
An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs
by Farkouh, Michael E., MD, MSc
The American journal of cardiology, 2009, Vol.103 (9), p.1227-1237
3.
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
by Farkouh, Michael E., MD, MSc
The American heart journal, 2008, Vol.155 (2), p.215-223
4.
Appropriate Cardiac Cath Lab activation: Optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction
by Rokos, Ivan C., MD
The American heart journal, 2010, Vol.160 (6), p.995-1003.e8
5.
Trends in the Prevalence, Awareness, Treatment and Control of High Low Density Lipoprotein-Cholesterol Among United States Adults From 1999–2000 Through 2009–2010
by Muntner, Paul, PhD
The American journal of cardiology, 2013, Vol.112 (5), p.664-670
6.
The role of primary care physician and cardiologist follow-up for low-risk patients with chest pain after emergency department assessment
by Czarnecki, Andrew, MD
The American heart journal, 2014, Vol.168 (3), p.289-295
7.
Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
by Farkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
Trends in cardiovascular medicine, 2015, Vol.25 (8), p.736-737
8.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
9.
Role of Insulin Resistance and Hyperglycemia in the Development of Atherosclerosis
by Bansilal, Sameer, MD
The American journal of cardiology, 2007, Vol.99 (4), p.6-14
10.
Ability of Low Antihypertensive Medication Adherence to Predict Statin Discontinuation and Low Statin Adherence in Patients Initiating Treatment After a Coronary Event
by Muntner, Paul, PhD
The American journal of cardiology, 2014, Vol.114 (6), p.826-831
11.
Optimal approaches to diabetic patients with multivessel disease
by Razzouk, Louai, MD, MPH
Trends in cardiovascular medicine, 2015, Vol.25 (7), p.625-631
12.
The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study en...
by Bansilal, Sameer, MD, MS
The American heart journal, 2012, Vol.164 (4), p.591-599
13.
Relation of Post–Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel C...
by Domanski, Michael, MD
The American journal of cardiology, 2016, Vol.118 (11), p.1655-1660
14.
Serum Cystatin C and Increased Coronary Heart Disease Prevalence in US Adults Without Chronic Kidney Disease
by Muntner, Paul, PhD
The American journal of cardiology, 2008, Vol.102 (1), p.54-57
15.
C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention
by Razzouk, Louai, MD
The American heart journal, 2009, Vol.158 (2), p.277-283
16.
Outcomes in patients with chest pain evaluated in a chest pain unit: The Chest Pain Evaluation in the Emergency Room study cohort
by Cullen, Michael W., MD
The American heart journal, 2011, Vol.161 (5), p.871-877
17.
Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction
by Ramanathan, Krishnan, MB, ChB
The American heart journal, 2011, Vol.162 (2), p.268-275
18.
Biomarkers After Risk Stratification in Acute Chest Pain (from the BRIC Study)
by Mathewkutty, Shiny, MD
The American journal of cardiology, 2013, Vol.111 (4), p.493-498
19.
Clustering of Metabolic Abnormalities Among Obese Patients and Mortality After Percutaneous Coronary Intervention
by Bashey, Sameer, MD
The American journal of cardiology, 2011, Vol.107 (10), p.1415-1420
20.
Thrombolysis In Myocardial Infarction (TIMI) Risk Score and Mortality in Patients With Advanced Chronic Kidney Disease and on Dialysis
by Baber, Usman, MD
The American journal of cardiology, 2009, Vol.103 (11), p.1513-1517
